A combination of intravesical BCG [corrected] and [corrected] electromotive mitomycin for high-risk superficial bladder cancer.
Kamat
Ashish M
AM
Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA. akamat@mdanderson.org
Dinney
Colin P N
CP